KEGG   DRUG: BrodalumabHelp
Entry
D10061                      Drug                                   

Name
Brodalumab (USAN);
Brodalumab (genetical recombination) (JAN)
Formula
C6372H9840N1712O1988S52
Exact mass
143814.699
Mol weight
143903.9676
Remark
Therapeutic category: 
ATC code: 
Comment
Monoclonal antibody
Treatment of inflammatory disease
Target
IL17RA (CD217) [HSA:23765] [KO:K05164]
  Pathway
Cytokine-cytokine receptor interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AC Interleukin inhibitors
     L04AC12 Brodalumab
      D10061  Brodalumab (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D10061  Brodalumab (USAN); Brodalumab (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  IL-17 receptor family
   interleukin 17 receptor
    Brodalumab
     D10061  Brodalumab (USAN)
BRITE hierarchy
Other DBs
CAS: 
1174395-19-7
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system